Dean Kamen adds Beta (BETA) shares; trust reports 764,330 held
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Beta Technologies, Inc. director Dean Kamen received 1,071 shares of Class A common stock on January 30, 2026 at a price of $0 per share. This brought his directly held Class A shares to 51,071. An additional 764,330 Class A shares are held indirectly by the Dean Kamen Revocable Trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Kamen Dean
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A common stock | 1,071 | $0.00 | -- |
| holding | Class A common stock | -- | -- | -- |
Holdings After Transaction:
Class A common stock — 51,071 shares (Direct);
Class A common stock — 764,330 shares (Indirect, By the Dean Kamen Revocable Trust)
Footnotes (1)
FAQ
What insider transaction did Beta Technologies (BETA) report for Dean Kamen?
Beta Technologies reported that director Dean Kamen received 1,071 Class A common shares. The shares were acquired on January 30, 2026 at a price of $0 per share, increasing his directly held Class A stake to 51,071 shares.
What is Dean Kamen’s role at Beta Technologies (BETA)?
Dean Kamen is reported as a director of Beta Technologies. The insider filing identifies his relationship to the issuer as a director, with no officer title or 10% owner status checked in the relationship section.
Were there any derivative securities reported for Dean Kamen at Beta Technologies (BETA)?
The insider report includes a table for derivative securities but shows no derivative positions or transactions for Dean Kamen. Only non-derivative Class A common stock holdings and the new 1,071-share acquisition are disclosed.